Skip to content

Follow up Glucose Levels Among Infants of Diabetic Mothers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00337142
Enrollment
250
Registered
2006-06-15
Start date
2006-06-30
Completion date
2006-12-31
Last updated
2009-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Mother, Full Term, Newborn

Keywords

gestational diabetes, newborn, hypoglycemia

Brief summary

Infants to diabetic mothers (IDM) are at risk for developing hypoglycemia after birth. Glucose level follow ups are recommended to each IDM. However, there are no recommendations as to how long this follow up should be performed for, nor are there safe glucose levels that allow stopping glucose monitoring. The aim of the study is to retrospectively follow up glucose levels among IDMs in order to find risk factors for developing hypoglycemia and determine time and glucose levels that would permit monitoring cessation.

Detailed description

A retrospective study of 250-300 IDMs, born in a single large medical center. Data will be collected as follows: Gestational age, birth weight, sex, delivery mode, type of maternal diabetes, other maternal diseases, feeding mode. Glucose levels as were recorded according to newborn protocol (1,2,4,6 hours after delivery, and then every 8 hours for total of 48 hours). Data of hypoglycemia treatment, if given, will be collected. Later we will statistically try to determine the risk factors for developing hypoglycemia and the safe time and glucose levels to stop monitoring.

Interventions

None listed

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 1 Days
Healthy volunteers
No

Inclusion criteria

* Full-term infants, diabetic mothers, Singleton

Exclusion criteria

* Preterm infants, multiple pregnancy, congenital malformations, clinically ill at birth.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026